J
Jess L. Kaplan
Researcher at Harvard University
Publications - 48
Citations - 1893
Jess L. Kaplan is an academic researcher from Harvard University. The author has contributed to research in topics: Inflammatory bowel disease & Medicine. The author has an hindex of 16, co-authored 39 publications receiving 1603 citations.
Papers
More filters
Journal ArticleDOI
Fecal Microbiota Transplant for Relapsing Clostridium difficile Infection Using a Frozen Inoculum From Unrelated Donors: A Randomized, Open-Label, Controlled Pilot Study
Ilan Youngster,Jenny Sauk,Christina Pindar,Robin G. Wilson,Jess L. Kaplan,Mark Smith,Eric J. Alm,Dirk Gevers,George Russell,Elizabeth L. Hohmann +9 more
TL;DR: In the initial feasibility study, FMT using a frozen inoculum from unrelated donors is effective in treating relapsing CDI and NGT administration appears to be as effective as colonoscopy administration.
Journal ArticleDOI
MicroRNA-124 Regulates STAT3 Expression and Is Down-regulated in Colon Tissues of Pediatric Patients With Ulcerative Colitis
Georgios Koukos,Christos Polytarchou,Jess L. Kaplan,Alessio Morley-Fletcher,Beatriz Gras-Miralles,Efi Kokkotou,Mariah Baril-Dore,Charalabos Pothoulakis,Harland S. Winter,Dimitrios Iliopoulos,Dimitrios Iliopoulos +10 more
TL;DR: Reduced levels of miR-124 in colon tissues of children with active UC appear to increase expression and activity of STAT3, which could promote inflammation and the pathogenesis of UC in children.
Journal ArticleDOI
The role of microbes in developmental immunologic programming.
TL;DR: The role of microorganisms in the gastrointestinal tract has undergone significant modification in the past few decades with new observations from clinical, epidemiologic, and basic science research as mentioned in this paper, and it is becoming increasingly clear that the gut microbiome plays an important role in a host's activities including digestion, protection from potentially pathogenic organisms, and the regulation and development of the host immune system.
Journal ArticleDOI
Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection
Ilan Youngster,Ilan Youngster,Jasmin Mahabamunuge,Hannah Systrom,Jenny Sauk,Hamed Khalili,Joanne Levin,Jess L. Kaplan,Elizabeth L. Hohmann +8 more
TL;DR: The effectiveness and safety of oral administration of frozen encapsulated fecal material, prepared from unrelated donors, in treating recurrent CDI are confirmed, and Randomized studies and FMT registries are still needed to ascertain long-term safety.
REVIEW ARTICLE The Role of Microbes in Developmental Immunologic Programming
TL;DR: Recent observations from a variety of fields help support the expansion of the “fetal programming hypothesis” to a host-microbe corollary that microbe-host interactions at critical windows influence the future immune phenotype, the maintenance of immune health, and the development of immune-mediated disease.